+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asthma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • PDF Icon

    Report

  • 115 Pages
  • April 2024
  • Region: Global
  • Acute Market Reports
  • ID: 5956558
Description Jump to:
The asthma treatment market is expected to grow at a CAGR of 4.5% during the forecast period of 2024 to 2032, driven by advancements in treatment options, increased awareness, and a growing patient population. Inhalers, oral medications, and combination therapies are gaining prominence, reflecting a shift toward personalized and effective asthma management. As the market evolves, it faces challenges related to accessibility and the need for innovative solutions to address the diverse needs of asthma patients globally. As North America leads in revenue and Europe emerges as a growth hub, key players' strategic initiatives underline the collaborative efforts shaping the market's trajectory. Overcoming challenges related to accessibility and advancing treatment options positions the asthma treatment market on a path of continuous evolution, contributing to improved asthma management globally.

Key Market Drivers

Advancements in Anti-inflammatory Drugs

The continuous development and advancements in Anti-inflammatory drugs constitute a significant driver for the asthma treatment market. These drugs, designed to reduce inflammation in the airways, play a pivotal role in managing asthma symptoms and preventing exacerbations. The introduction of novel anti-inflammatory agents with improved efficacy and safety profiles has contributed to increased adoption and patient compliance.

Growing Demand for Inhalers

The growing demand for Inhalers is a noteworthy driver propelling the market. Inhalers provide a convenient and effective way to administer asthma medications directly to the airways. With advancements such as smart inhalers and the availability of a variety of inhaler types, including metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), the market is witnessing a surge in demand, leading to substantial revenue and a notable CAGR.

Increasing Adoption of Long-term Asthma Control Medications

The increasing adoption of Long-term Asthma Control Medications is a key driver shaping the market dynamics. Patients and healthcare providers are recognizing the importance of maintaining asthma control over the long term to prevent symptoms and improve quality of life. Evidence supporting this driver includes the rising prescription rates for long-term control medications and their contribution to the overall market revenue and CAGR.

Restraint

Limited Accessibility to asthma treatment

Despite the advancements in asthma treatment options, a notable restraint is the limited accessibility to these treatments, particularly in certain regions and demographic segments. Disparities in healthcare infrastructure, economic factors, and awareness levels contribute to uneven accessibility. This constraint impacts the widespread adoption of effective asthma management strategies, hindering the market's potential for reaching a larger patient population.

Market Segmentation Analysis

Market by Drug Class: Anti-inflammatory drugs Dominate the Market

In 2023, Anti-inflammatory drugs emerged as the revenue leader, with a notable CAGR, indicating sustained market growth. Bronchodilators, contributing to quick relief, showcased a considerable CAGR, while Combination Therapy demonstrated a balanced approach. Evidence supporting this includes prescription trends, clinical trial outcomes, and patient preferences driving the dominance of certain drug classes in revenue and CAGR.

Market by Product: Inhalers Dominate the Market

Inhalers led both in revenue and CAGR in 2023, underscoring their central role in asthma management. Nebulizers exhibited a higher CAGR, reflecting specific clinical scenarios where their use is preferred. Evidence supporting this segmentation includes prescription patterns, technological advancements, and patient preferences influencing the market dynamics for inhalers and nebulizers.

Market by Gender: Male Segment to Witness Strong CAGR During the Forecast Period

In 2023, both Female and Male segments contributed significantly to the market, with similar revenue shares. However, a higher CAGR was observed in the Male segment, reflecting a growing awareness and acceptance of asthma management strategies among males. Evidence supporting this includes demographic trends, healthcare-seeking behavior, and marketing efforts targeting gender-specific asthma awareness.

Market by Route of Administration: Inhaled Medications Dominate the Market

Inhaled medications led in both revenue and CAGR in 2023, showcasing their effectiveness in delivering asthma medications directly to the airways. Oral medications and other routes of administration exhibited distinct roles in certain patient populations. Evidence supporting this includes clinical trial outcomes, patient preferences, and healthcare provider recommendations influencing the choice of route of administration.

Market by Treatment Type: Long-term Asthma Control Medications Dominate the Market

Long-term Asthma Control Medications led in both revenue and CAGR in 2023, emphasizing the importance of sustained asthma management. Quick-relief (Rescue) Medications showcased a considerable CAGR, reflecting their role in providing immediate relief during exacerbations. Evidence supporting this segmentation includes prescription trends, clinical guidelines, and patient adherence patterns influencing the market dynamics for different treatment types.

North America Remains the Global Leader

North America emerged as the region with the highest revenue and CAGR in 2023, driven by a well-established healthcare infrastructure, high awareness levels, and a growing prevalence of asthma. Evidence supporting this includes epidemiological data, healthcare expenditure trends, and regional healthcare policies influencing the market dynamics. Europe exhibited substantial growth potential, with a focus on advancing treatment options and increasing awareness.

Market Competition to Intensify during the Forecast Period

Top players in the asthma treatment market in 2023 included GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Mylan N.V, F. Hoffmann-La Roche Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Merck & Co. Inc., Novartis International AG, Sanofi, Sunovion Pharmaceuticals, Inc., and Teva Pharmaceutical Industries. These players implemented key strategies such as product innovations, strategic collaborations, and global expansion to maintain their market positions. GlaxoSmithKline plc's commitment to research and development is evident in its diverse asthma treatment portfolio, including both inhalers and oral medications. AstraZeneca's global collaborations and focus on patient education contribute to its competitive standing. Boehringer Ingelheim International GmbH's emphasis on personalized medicine and digital health solutions reflects its commitment to advancing asthma management.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Asthma Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Asthma Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

  • Anti-inflammatory
  • Bronchodilators
  • Combination Therapy

Product

  • Inhalers
  • Dry powder inhalers
  • Metered dose inhalers
  • Soft mist inhalers
  • Nebulizers

Route of Administration

  • Oral
  • Inhaled
  • Others

Treatment Type

  • Long-term Asthma Control Medications
  • Quick-relief (Rescue) Medications

Region Segment (2022 - 2032; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Asthma Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Asthma Treatment market?
  • Which is the largest regional market for Asthma Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Asthma Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Asthma Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Asthma Treatment Market
2.2. Global Asthma Treatment Market, By Drug Class, 2023 (US$ Million)
2.3. Global Asthma Treatment Market, By Product, 2023 (US$ Million)
2.4. Global Asthma Treatment Market, By Route of Administration, 2023 (US$ Million)
2.5. Global Asthma Treatment Market, By Treatment Type, 2023 (US$ Million)
2.6. Global Asthma Treatment Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023
3. Asthma Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Asthma Treatment Market Vendors
3.2. Strategies Adopted by Asthma Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Asthma Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Asthma Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Anti-inflammatory
5.3.2. Bronchodilators
5.3.3. Combination Therapy
6. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Inhalers
6.3.1.1. Dry powder inhalers
6.3.1.2. Metered dose inhalers
6.3.1.3. Soft mist inhalers
6.3.2. Nebulizers
7. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Inhaled
7.3.3. Others
8. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Long-term Asthma Control Medications
8.3.2. Quick-relief (Rescue) Medications
9. North America Asthma Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
9.4. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
9.6. Asthma Treatment Market: By Region, 2022-2032, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.6.1.1.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
9.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.6.1.2.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
9.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.6.1.3.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
9.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10. UK and European Union Asthma Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.4. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6. Asthma Treatment Market: By Region, 2022-2032, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.1.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.2.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.3.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.4.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.4.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.4.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.5.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.5.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.5.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.6.1.6.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
10.6.1.6.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.6.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11. Asia Pacific Asthma Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.3. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.4. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.5. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6. Asthma Treatment Market: By Region, 2022-2032, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.1.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.2.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.3.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.4.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.4.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.4.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.5.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.5.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.5.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.6.1.6.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
11.6.1.6.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.6.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
12. Latin America Asthma Treatment Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.3. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
12.4. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.5. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
12.6. Asthma Treatment Market: By Region, 2022-2032, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.6.1.1.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
12.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.6.1.2.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
12.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.6.1.3.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
12.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
13. Middle East and Africa Asthma Treatment Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
13.3. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
13.4. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.5. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
13.6. Asthma Treatment Market: By Region, 2022-2032, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
13.6.1.1.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
13.6.1.1.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.1.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
13.6.1.2.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
13.6.1.2.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.2.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Asthma Treatment Market: By Drug Class, 2022-2032, USD (Million)
13.6.1.3.2. Asthma Treatment Market: By Product, 2022-2032, USD (Million)
13.6.1.3.3. Asthma Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.3.4. Asthma Treatment Market: By Treatment Type, 2022-2032, USD (Million)
14. Company Profile
14.1. GlaxoSmithKline plc
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. AstraZeneca
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Boehringer Ingelheim International GmbH
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Mylan N.V
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. F. Hoffmann-La Roche Ltd.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Lupin Pharmaceuticals
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Glenmark Pharmaceuticals
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Merck & Co. Inc.
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Novartis International AG
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Sanofi
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Sunovion Pharmaceuticals, Inc.
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Teva Pharmaceutical Industries
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
List of Figures
FIG. 1 Global Asthma Treatment Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Asthma Treatment Market: Quality Assurance
FIG. 5 Global Asthma Treatment Market, By Drug Class, 2023
FIG. 6 Global Asthma Treatment Market, By Product, 2023
FIG. 7 Global Asthma Treatment Market, By Route of Administration, 2023
FIG. 8 Global Asthma Treatment Market, By Treatment Type, 2023
FIG. 9 Global Asthma Treatment Market, By Geography, 2023
FIG. 10 Market Geographical Opportunity Matrix - Global Asthma Treatment Market, 2023
FIG. 11 Market Positioning of Key Asthma Treatment Market Players, 2023
FIG. 12 Global Asthma Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
FIG. 13 Global Asthma Treatment Market, By Drug Class, 2023 Vs 2032, %
FIG. 14 Global Asthma Treatment Market, By Product, 2023 Vs 2032, %
FIG. 15 Global Asthma Treatment Market, By Route of Administration, 2023 Vs 2032, %
FIG. 16 Global Asthma Treatment Market, By Treatment Type, 2023 Vs 2032, %
FIG. 17 U.S. Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 18 Canada Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 19 Rest of North America Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 20 UK Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 21 Germany Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 22 Spain Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 23 Italy Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 24 France Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 25 Rest of Europe Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 26 China Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 27 Japan Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 28 India Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 29 Australia Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 30 South Korea Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 31 Rest of Asia Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 32 Brazil Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 33 Mexico Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 34 Rest of Latin America Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 35 GCC Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 36 Africa Asthma Treatment Market (US$ Million), 2022 - 2032
FIG. 37 Rest of Middle East and Africa Asthma Treatment Market (US$ Million), 2022 - 2032
List of Tables
Table 1 Global Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 2 Global Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 3 Global Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 4 Global Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 5 Global Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 6 North America Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 7 North America Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 8 North America Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 9 North America Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 10 North America Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 11 U.S. Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 12 U.S. Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 13 U.S. Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 14 U.S. Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 15 U.S. Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 16 Canada Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 17 Canada Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 18 Canada Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 19 Canada Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 20 Canada Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 21 Rest of North America Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 22 Rest of North America Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 23 Rest of North America Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 24 Rest of North America Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 25 Rest of North America Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 26 UK and European Union Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 27 UK and European Union Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 28 UK and European Union Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 29 UK and European Union Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 30 UK and European Union Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 31 UK Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 32 UK Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 33 UK Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 34 UK Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 35 UK Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 36 Germany Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 37 Germany Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 38 Germany Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 39 Germany Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 40 Germany Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 41 Spain Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 42 Spain Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 43 Spain Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 44 Spain Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 45 Spain Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 46 Italy Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 47 Italy Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 48 Italy Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 49 Italy Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 50 Italy Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 51 France Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 52 France Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 53 France Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 54 France Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 55 France Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 56 Rest of Europe Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 57 Rest of Europe Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 58 Rest of Europe Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 59 Rest of Europe Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 60 Rest of Europe Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 61 Asia Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 62 Asia Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 63 Asia Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 64 Asia Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 65 Asia Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 66 China Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 67 China Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 68 China Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 69 China Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 70 China Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 71 Japan Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 72 Japan Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 73 Japan Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 74 Japan Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 75 Japan Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 76 India Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 77 India Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 78 India Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 79 India Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 80 India Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 81 Australia Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 82 Australia Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 83 Australia Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 84 Australia Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 85 Australia Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 86 South Korea Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 87 South Korea Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 88 South Korea Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 89 South Korea Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 90 South Korea Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 91 Latin America Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 92 Latin America Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 93 Latin America Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 94 Latin America Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 95 Latin America Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 96 Brazil Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 97 Brazil Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 98 Brazil Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 99 Brazil Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 100 Brazil Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 101 Mexico Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 102 Mexico Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 103 Mexico Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 104 Mexico Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 105 Mexico Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 106 Rest of Latin America Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 107 Rest of Latin America Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 108 Rest of Latin America Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 109 Rest of Latin America Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 110 Rest of Latin America Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 111 Middle East and Africa Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 112 Middle East and Africa Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 113 Middle East and Africa Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 114 Middle East and Africa Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 115 Middle East and Africa Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 116 GCC Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 117 GCC Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 118 GCC Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 119 GCC Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 120 GCC Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 121 Africa Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 122 Africa Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 123 Africa Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 124 Africa Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 125 Africa Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)
Table 126 Rest of Middle East and Africa Asthma Treatment Market By Drug Class, 2022-2032, USD (Million)
Table 127 Rest of Middle East and Africa Asthma Treatment Market By Product, 2022-2032, USD (Million)
Table 128 Rest of Middle East and Africa Asthma Treatment Market By Inhalers, 2022-2032, USD (Million)
Table 129 Rest of Middle East and Africa Asthma Treatment Market By Route of Administration, 2022-2032, USD (Million)
Table 130 Rest of Middle East and Africa Asthma Treatment Market By Treatment Type, 2022-2032, USD (Million)

Companies Mentioned

  • GlaxoSmithKline plc
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Mylan N.V
  • F. Hoffmann-La Roche Ltd.
  • Lupin Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Merck & Co. Inc.
  • Novartis International AG
  • Sanofi
  • Sunovion Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries

Related Topics

Related Reports

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032 - Product Image

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti- inflammatory, Bronchodilators), Product (Inhalers, Nebulizers), Routeof Administration (Oral, Inhaled), Region, and Segment Forecasts, 2024-2030 - Product Image

Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti- inflammatory, Bronchodilators), Product (Inhalers, Nebulizers), Routeof Administration (Oral, Inhaled), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Image

COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
COPD & Asthma Devices Market by Product Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Image

COPD & Asthma Devices Market by Product Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.